dc.contributor.author | Hashemi, H | |
dc.contributor.author | Namazi, H | |
dc.date.accessioned | 2018-08-26T06:35:31Z | |
dc.date.available | 2018-08-26T06:35:31Z | |
dc.date.issued | 2018 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/44212 | |
dc.description.abstract | A new blue fluorescent surface modified graphene oxide (GO) by 6-(5-bromothiophen-2-yl) benzo[c][1,2,5]selenadiazole-5-carboxylic acid (TB) denoted as (GO-TB) was synthesized. The obtained hybrid was characterized by Scanning Electron Microscope (SEM/EDS); Brunauer-Emmett-Teller (BET); X-Ray Diffraction Spectroscopy (XRD); X-Ray Photoelectron Spectroscopy (XPS); UV-Vis Absorption Spectroscopy, and Fourier Transformed Infrared Spectroscopy (FTIR). The synthesized TB moiety displayed orange emission around 590 nm, while GO-TB exhibited a blue photoluminescence around 431 and 159 nm blue shift of photoluminescence. Doxorubicin immobilized on the hybrid surface up to 93%, and the release behavior in three different pHs was investigated. The release profile indicated a pH-dependent liberation with Fickian diffusion mechanism. The cytotoxicity of the hybrid was studied and the IC50 value for the hybrid was 5.16 A mu g/ml. | |
dc.language.iso | English | |
dc.relation.ispartof | APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING | |
dc.title | Synthesis and characterization of blue fluorescent surface modified nano-graphene oxide flakes as a pH-sensitive drug delivery system | |
dc.type | Article | |
dc.citation.volume | 124 | |
dc.citation.issue | 7 | |
dc.citation.index | Web of science | |
dc.identifier.DOI | https://doi.org/10.1007/s00339-018-1898-5 | |